1. Why not use data intensive science to build models of disease within a commons? Power of a Compute Space/Beyond Current Reward Structures Five Pilots- Missing Ingredients…

1. it is more about how we do science than whatadvantages of an open innovation compute spacefor building better models of diseasebeyond siloed drug discovery- Arch2POCM…

Slide 1 RESPONSE EVALUATION CRITERIA IN SOLID TUMORS (RECIST) New Guidelines to Evaluate the Response to Treatment in Solid Tumors P Therasse, SG Arbuck, EA Eisenhauer, J…

Tumor Measurement Criteria milestones - 1981 & 2000 RESPONSE EVALUATION CRITERIA IN SOLID TUMORS (RECIST) New Guidelines to Evaluate the Response to Treatment in Solid…

Tumor Measurement Criteria milestones - 1981 & 2000 RESPONSE EVALUATION CRITERIA IN SOLID TUMORS (RECIST) New Guidelines to Evaluate the Response to Treatment in Solid…